查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451033

2024-2032 年按藥物類別、適應症、配銷通路和地區分類的疼痛管理藥物市場報告

Pain Management Drugs Market Report by Drug Class, Indication, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球疼痛管理藥物市場規模達到697億美元。展望未來， IMARC Group預計到2032年市場規模將達到872億美元，2024-2032年複合年成長率（CAGR）為2.4%。由於慢性病盛行率不斷上升、疼痛管理療法的快速進步、疼痛管理意識和教育的提高、支持性政府和監管框架的實施以及對有效術後疼痛管理的需求不斷成長，市場正在經歷強勁成長。

疼痛管理藥物市場分析：

市場成長與規模：在慢性病盛行率不斷上升、疼痛管理療法快速進步以及對有效和更安全的疼痛緩解方案的需求不斷成長的推動下，市場正在穩定成長。

主要市場促進因素：影響市場成長的主要促進因素包括關節炎和癌症發病率上升、藥物開發技術的快速進步、疼痛管理意識和教育的提高以及政府支持政策的實施。

主要市場趨勢：主要市場趨勢涉及在全球鴉片類藥物危機和對更安全的疼痛管理方案的需求的推動下，不斷轉向非鴉片類藥物的開發。此外，人們越來越關注個人化醫療和藥物基因組學，以提供更有針對性和更有效的疼痛管理策略，這也促進了市場的成長。

地理趨勢：由於先進的醫療保健系統、慢性疼痛的高盛行率以及不斷努力開發替代性疼痛管理療法，北美在市場上處於領先地位。在醫療基礎設施增加、慢性病盛行率上升和製藥業擴張的推動下，其他地區也出現了顯著成長。

競爭格局：市場的特點是主要參與者積極參與，他們參與研發（R＆D）、合作和併購等策略性舉措，以增強其市場地位。此外，該公司還專注於創新並擴展其產品組合，以包括新穎且有效的疼痛管理解決方案。

挑戰與機會：市場面臨各種挑戰，例如需要平衡鴉片類藥物使用的功效與安全性以及應對複雜的監管環境。然而，新治療領域的發展以及對個人化疼痛管理方法的日益關注，正在為市場成長創造新的機會。

疼痛管理藥物市場趨勢：

慢性病盛行率增加

關節炎、癌症、糖尿病和心臟病等慢性疾病的發生率不斷上升，需要使用止痛藥物，這是推動市場成長的主要因素之一。此外，擴大使用疼痛管理藥物來改善患者的生活品質，這也是一種生長誘導因素。此外，全球不斷成長的易患骨關節炎和神經性疼痛等慢性病的老年人口正在放大市場的成長。除此之外，生活方式的不斷變化導致肥胖和缺乏身體活動等風險因素增加，正在推動市場成長。此外，慢性病疼痛日益複雜，需要採用多模式方法進行疼痛管理，這正在擴大市場的成長。

疼痛管理療法的快速進步

疼痛管理技術的快速進步，導致了新的、更有效的藥物（包括生物製劑和標靶治療）的開發，為市場成長創造了積極的前景。與此一致的是，減少傳統疼痛治療藥物副作用的治療功效不斷提高，有利於市場成長。此外，製藥業對研發 (R&D) 的日益關注，導致推出具有更好疼痛管理特性的藥物，為市場成長創造了積極的前景。此外，個人化醫療和藥物基因組學的日益普及，可以實現更有針對性和更有效的疼痛管理策略，預計將推動市場成長。

對疼痛管理的認知不斷增強

醫療保健專業人員和患者對疼痛管理的認知和教育不斷提高是推動市場成長的主要因素。此外，有能力開出適當疼痛管理藥物的醫療保健提供者的理解和培訓的不斷加深，也促進了市場的成長。同時，越來越多的患者了解藥物的好處和影響，促使他們尋求治療疼痛的方法，從而推動了市場的成長。除此之外，政府和醫療機構實施的各種宣傳活動和教育計畫也是促進成長的因素。與此一致的是，推出了多項專注於纖維肌痛和神經性疼痛等慢性疼痛疾病管理的舉措，以提高人們對這些疾病和可用治療方案的認知，這對市場成長產生了積極影響。

不斷增加的政府和監管支持

支持新藥開發和批准的各種政府措施和政策的實施正在為市場成長創造積極的前景。據此，孤兒藥開發快速核准和激勵措施的引入，鼓勵製藥公司投資新的疼痛管理療法，預計將推動市場成長。此外，政府資助的醫療保健計劃和報銷政策的實施直接影響疼痛管理藥物的可近性和可負擔性，為市場成長提供了相當大的推動力。此外，越來越多的計畫旨在增加服務不足地區獲得疼痛管理藥物的機會，並認知到疼痛管理是公共衛生的關鍵組成部分，正在促進市場成長。同時，對新型疼痛管理療法研究的資助和補助金不斷增加，鼓勵創新和發展，這為市場成長提供了動力。

增加外科手術和術後疼痛管理

全球外科手術的不斷增加，推動了對疼痛管理藥物的需求，從而推動了市場的成長。此外，廣泛使用術後疼痛管理來促進患者復健正在推動市場成長。除此之外，選擇性和微創（MI）外科手術的日益普及，導致對有效疼痛管理藥物的需求相應增加，預計將推動市場成長。外科手術會導致急性疼痛，需要進行管理以促進患者康復並預防併發症。除此之外，有效的術後疼痛管理可以提高患者的舒適度，並降低血栓形成、肺部問題和慢性疼痛症候群等術後併發症的風險。除此之外，醫院對加速復健外科（ERAS）方案的日益重視，凸顯了有效疼痛管理策略的重要性，正在為市場創造積極的前景。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球疼痛管理藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：依藥品類別
  • 市場區隔：依指標
  • 市場區隔：按配銷通路
  • 市場區隔：按地區
  • 市場預測

第 6 章：市場區隔：依藥物類別

  • 非類固醇抗發炎藥
    • 市場走向
    • 市場預測
  • 麻醉劑
    • 市場走向
    • 市場預測
  • 抗驚厥藥
    • 市場走向
    • 市場預測
  • 抗偏頭痛劑
    • 市場走向
    • 市場預測
  • 抗憂鬱藥
    • 市場走向
    • 市場預測
  • 鴉片類藥物
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依跡象

  • 肌肉骨骼疼痛
    • 市場走向
    • 市場預測
  • 手術和創傷疼痛
    • 市場走向
    • 市場預測
  • 癌症痛
    • 市場走向
    • 市場預測
  • 神經性疼痛
    • 市場走向
    • 市場預測
  • 偏頭痛
    • 市場走向
    • 市場預測
  • 產科疼痛
    • 市場走向
    • 市場預測
  • 纖維肌痛
    • 市場走向
    • 市場預測
  • 燒傷痛
    • 市場走向
    • 市場預測
  • 牙齒/臉部疼痛
    • 市場走向
    • 市場預測
  • 小兒疼痛
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories, Inc.
    • Pfizer, Inc.
    • Eli Lilly & Company
    • Endo International plc
    • F. Hoffmann-La Roche AG
    • Bausch Health Companies, Inc.
    • Merck & Co. Inc.
    • Allergen Inc.
    • Novartis International AG
    • Johnson & Johnson Private Limited
    • GlaxoSmithKline Plc
    • Purdue Pharma LP
Product Code: SR112024A1330

The global pain management drugs market size reached US$ 69.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 87.2 Billion by 2032, exhibiting a growth rate (CAGR) of 2.4% during 2024-2032. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, heightened awareness and education about pain management, the implementation of supportive government and regulatory frameworks, and the rising demand for effective post-operative pain management.

Pain Management Drugs Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, and the growing demand for effective and safer pain relief options.

Major Market Drivers: Key drivers influencing the market growth include the rising incidence of arthritis and cancer, rapid technological advancements in drug development, increasing awareness and education about pain management, and the implementation of supportive government policies.

Key Market Trends: The key market trends involve the ongoing shift towards the development of non-opioid medications, driven by the global opioid crisis and the need for safer pain management options. Additionally, the increasing focus on personalized medicine and pharmacogenomics that offer more targeted and effective pain management strategies, is bolstering the market growth.

Geographical Trends: North America leads the market due to advanced healthcare systems, high prevalence of chronic pain, and ongoing efforts to develop alternative pain management therapies. Other regions are also showing significant growth, fueled by increasing healthcare infrastructure, rising chronic disease prevalence, and expanding pharmaceutical sectors.

Competitive Landscape: The market is characterized by the active involvement of key players who are engaged in strategic initiatives such as research and development (R&D), collaborations, and mergers and acquisitions to enhance their market position. Furthermore, companies are focusing on innovation and expanding their product portfolios to include novel and effective pain management solutions.

Challenges and Opportunities: The market faces various challenges, such as the need for balancing efficacy with safety in opioid use and navigating complex regulatory environments. However, the development of new therapeutic areas, and growing focus on personalized pain management approaches, are creating new opportunities for the market growth.

Pain Management Drugs Market Trends:

Increasing prevalence of chronic diseases

The rising incidence of chronic diseases, such as arthritis, cancer, diabetes, and heart disease, necessitating the use of pain management drugs, is one of the major factors boosting the market growth. Moreover, the increasing utilization of pain management drugs to improve the quality of life of patients, is acting as a growth-inducing factor. Additionally, the growing geriatric population across the globe who are susceptible to chronic conditions, such as osteoarthritis and neuropathic pain, is amplifying the market growth. In addition to this, the rising lifestyle changes, leading to an increase in risk factors, like obesity and physical inactivity, is driving the market growth. Furthermore, the increasing complexity of pain in chronic diseases requiring a multimodal approach to pain management is expanding the market growth.

Rapid advancements in pain management therapies

The rapid technological advancements in pain management, leading to the development of new and more effective drugs, including biologics and targeted therapies, is creating a positive outlook for the market growth. In line with this, the rising improvements in the efficacy of treatments to reduce side effects associated with traditional pain management drugs, is favoring the market growth. Additionally, the increasing focus by the pharmaceutical industry on research and development (R&D), leading to the introduction of drugs with better pain management profiles, is creating a positive outlook for the market growth. Additionally, the rising popularity of personalized medicine and pharmacogenomics that enable more targeted and effective pain management strategies, is anticipated to drive the market growth.

Growing awareness about pain management

The increasing awareness and education about pain management among healthcare professionals and patients is a major factor propelling the market growth. Moreover, the rising understanding and training among healthcare providers who are equipped to prescribe appropriate pain management drugs, is contributing to the market growth. Along with this, the growing education among patients about the benefits and implications of drugs, prompting them to seek treatment for their pain, is boosting the market growth. Besides this, the implementation of various awareness campaigns and educational programs by governments and healthcare organizations is acting as a growth-inducing factor. In line with this, the introduction of several initiatives focusing on the management of chronic pain conditions, like fibromyalgia and neuropathic pain to increase awareness about the conditions and the available treatment options, is positively influencing the market growth.

Rising government and regulatory support

The imposition of various government initiatives and policies that support the development and approval of new drugs is creating a positive outlook for the market growth. In line with this, the introduction of fast-track approvals and incentives for orphan drug development that encourage pharmaceutical companies to invest in new pain management therapies, is anticipated to drive the market growth. Furthermore, the implementation of government-funded healthcare programs and reimbursement policies that directly influence the accessibility and affordability of pain management drugs, is providing a considerable boost to the market growth. Additionally, the growing establishment of programs to increase access to pain management drugs in underserved areas, recognizing pain management as a key component of public health, is fostering the market growth. Along with this, the rising initiatives in funding and grants for research in novel pain management therapies, encouraging innovation and development is providing an impetus to the market growth.

Increasing surgical procedures and post-operative pain management

The rising surgical procedures across the globe, driving the demand for pain management drugs is fueling the market growth. Moreover, the widespread utilization of post-operative pain management for patient recovery is boosting the market growth. Besides this, the increasing prevalence of elective and minimally invasive (MI) surgical procedures, leading to a corresponding rise in the demand for effective pain management drugs is anticipated to drive the market growth. Surgical procedures result in acute pain that requires management to facilitate patient recovery and prevent complications. In addition to this, effective post-operative pain management improves patient comfort and reduces the risk of post-surgical complications such as thrombosis, pulmonary issues, and chronic pain syndromes. Apart from this, the growing emphasis on enhanced recovery after surgery (ERAS) protocols in hospitals, highlighting the importance of effective pain management strategies, is creating a positive outlook for the market.

Pain Management Drugs Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on drug class, indication, and distribution channel.

Breakup by Drug Class:

NSAIDs

Anesthetics

Anticonvulsants

Antimigraine Agents

Antidepressants

Opioids

Others

Opioids accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes NSAIDs, anesthetics, anticonvulsants, antimigraine agents, antidepressants, opioids, and others. According to the report, opioids represented the largest segment.

Breakup by Indication:

Musculoskeletal Pain

Surgical and Trauma Pain

Cancer Pain

Neuropathic Pain

Migraine Pain

Obstetrical Pain

Fibromyalgia Pain

Burn Pain

Dental/Facial Pain

Pediatric Pain

Others

Musculoskeletal pain holds the largest share in the industry

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine pain, obstetrical pain, fibromyalgia pain, burn pain, dental/facial pain, pediatric pain, and others. According to the report, musculoskeletal pain accounted for the largest market share.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Hospital pharmacies represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America leads the market, accounting for the largest pain management drugs market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories, Inc.

Pfizer, Inc.

Eli Lilly & Company

Endo International plc

F. Hoffmann-La Roche AG

Bausch Health Companies, Inc.

Merck & Co. Inc.

Allergen Inc.

Novartis International AG

Johnson & Johnson Private Limited

GlaxoSmithKline Plc

Purdue Pharma L.P.

Key Questions Answered in This Report

  • 1. What was the global pain management drugs market size in 2023?
  • 2. How will the global pain management drugs market perform over the next five years 2024-2032?
  • 3. What is the impact of COVID-19 on the global pain management drugs market?
  • 4. What are the key global pain management drugs market drivers?
  • 5. What are the major trends in the global pain management drugs market?
  • 6. What is the leading drug class in the global pain management drugs market?
  • 7. What is the major indication in the global pain management drugs market?
  • 8. What is the global pain management drugs market breakup by distribution channel?
  • 9. What are the major regions in the global pain management drugs market?
  • 10. Who are the leading pain management drug manufacturers?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pain Management Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Drug Class
  • 5.5 Market Breakup by Indication
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 NSAIDs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Anesthetics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Anticonvulsants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Antimigraine Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antidepressants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Opioids
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Pain
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surgical and Trauma Pain
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cancer Pain
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neuropathic Pain
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Migraine Pain
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Obstetrical Pain
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Fibromyalgia Pain
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Burn Pain
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Dental/Facial Pain
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Pediatric Pain
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.11.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories, Inc.
    • 14.3.2 Pfizer, Inc.
    • 14.3.3 Eli Lilly & Company
    • 14.3.4 Endo International plc
    • 14.3.5 F. Hoffmann-La Roche AG
    • 14.3.6 Bausch Health Companies, Inc.
    • 14.3.7 Merck & Co. Inc.
    • 14.3.8 Allergen Inc.
    • 14.3.9 Novartis International AG
    • 14.3.10 Johnson & Johnson Private Limited
    • 14.3.11 GlaxoSmithKline Plc
    • 14.3.12 Purdue Pharma L.P

List of Figures

  • Figure 1: Global: Pain Management Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Pain Management Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pain Management Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 4: Global: Pain Management Drugs Market: Breakup by Indication (in %), 2023
  • Figure 5: Global: Pain Management Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Pain Management Drugs Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Pain Management Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Pain Management Drugs Industry: SWOT Analysis
  • Figure 9: Global: Pain Management Drugs Industry: Value Chain Analysis
  • Figure 10: Global: Pain Management Drugs Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Pain Management Drugs (NSAIDs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Pain Management Drugs (NSAIDs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Pain Management Drugs (Anesthetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Pain Management Drugs (Anesthetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Pain Management Drugs (Anticonvulsants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Pain Management Drugs (Anticonvulsants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Pain Management Drugs (Antimigraine Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Pain Management Drugs (Antimigraine Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Pain Management Drugs (Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Pain Management Drugs (Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Pain Management Drugs (Opioids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Pain Management Drugs (Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Pain Management Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Pain Management Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Pain Management Drugs (Musculoskeletal Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Pain Management Drugs (Musculoskeletal Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Pain Management Drugs (Surgical and Trauma Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Pain Management Drugs (Surgical and Trauma Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Pain Management Drugs (Cancer Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Pain Management Drugs (Cancer Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Pain Management Drugs (Neuropathic Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Pain Management Drugs (Neuropathic Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Pain Management Drugs (Migraine Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Pain Management Drugs (Migraine Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Pain Management Drugs (Obstetrical Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Pain Management Drugs (Obstetrical Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Pain Management Drugs (Fibromyalgia Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Pain Management Drugs (Fibromyalgia Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Pain Management Drugs (Burn Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Pain Management Drugs (Burn Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Pain Management Drugs (Dental/Facial Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Pain Management Drugs (Dental/Facial Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Pain Management Drugs (Pediatric Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Pain Management Drugs (Pediatric Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Pain Management Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Pain Management Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Pain Management Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2018 & 2023
  • Figure 48: Global: Pain Management Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2024-2032
  • Figure 49: Global: Pain Management Drugs Market: Sales through Retail Pharmacies (in Million US$), 2018 & 2023
  • Figure 50: Global: Pain Management Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2024-2032
  • Figure 51: Global: Pain Management Drugs Market: Sales through Online Pharmacies (in Million US$), 2018 & 2023
  • Figure 52: Global: Pain Management Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2024-2032
  • Figure 53: North America: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia Pacific: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia Pacific: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Middle East and Africa: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Middle East and Africa: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Pain Management Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pain Management Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Pain Management Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Pain Management Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Pain Management Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pain Management Drugs Market Structure
  • Table 7: Global: Pain Management Drugs Market: Key Players